GPs should be central to disaster relief: RACGP The college has called for governments to better utilise primary care when natural disasters strike.
Workforce strategy and recruitment: RACGP position The college responds to proposed solutions to issues facing the current and future medical workforce.
COVID-19: Business resilience In this episode, hosts Dr Billy Stoupas and Dr Gillian Singleton speak with Dr Todd Cameron, Acting Chair of the RACGP Specific Interests Business of General Practice network. He discusses the impact of COVID-19 on business operations and the introduction of telehealth, including the challenges and opportunities this has presented. There is also a Q&A session with Stephen Halmarick, Chief Economist at Commonwealth Bank. Subscribe now to hear the latest episodes of Generally Speaking.
What will general practice look like after the pandemic? The coronavirus will have long-lasting effects on how primary care is delivered, writes Dr Edwin Kruys.
Rent reduction push putting practices under major financial strain Two of Australia’s largest pathology companies are pushing GPs to halve their rent for co-located collection centres.
Circumstances change, good practice stays the same Coronavirus has affected nearly every aspect of our lives, including patient consultations, but the basics of quality general practice remain, Associate Professor Charlotte Hespe writes.
RACGP research grants to help uncover pandemic impact on GPs Expressions of interest are now open for high-quality research projects relating to COVID-19 and general practice.
Using virtual reality to reduce procedural pain in general practice Routine immunisations are a common reason children experience pain and distress as a result of interacting with a healthcare provider.
GP efforts in the coronavirus fight ‘inspiring to witness’ Dr James Best discusses the challenges and trauma involved in ‘what is possibly the most trying professional experience in our lives’.
New coronavirus test could be ‘game-changing’ The point-of-care test aims to rapidly determine a person’s immunity to coronavirus and how at-risk they are of contracting severe disease.